机译:我们可以识别患有骨关节炎进展的高风险的患者,谁会回应治疗? 重点关注骨关节炎的流行病学和表型(Vol 32,PG 179,2015)
Univ Liege Dept Publ Hlth Epidemiol &
Hlth Econ CHU Sart Tilman B23 B-4000 Liege Belgium;
Univ Southampton MRC Lifecourse Epidemiol Unit Southampton Hants England;
Univ Southampton MRC Lifecourse Epidemiol Unit Southampton Hants England;
Univ Novade Lisboa CEDOC Dept Rheumatol Fac Ciencias Med CHLO EPE Hosp Egas Moniz Lisbon;
Univ Florence Dept Surg &
Translat Med Bone Metab Unit Florence Italy;
UAM Fdn Jimenez Diaz IIS Dept Rheumatol Bone &
Joint Res Unit Madrid Spain;
Pierre &
Marie Curie Univ St Antoine Hosp AP HP Dept Rheumatol Paris France;
Univ Southampton MRC Lifecourse Epidemiol Unit Southampton Hants England;
Catholic Univ Louvain St Luc Univ Hosp Dept Rheumatol Brussels Belgium;
Univ Maryland Sch Med Dept Med Baltimore MD 21201 USA;
Univ Sheffield Ctr Metab Bone Dis Sch Med Sheffield S Yorkshire England;
Austrian Agcy Hlth &
Food Safety AGES Sci Off Vienna Austria;
Tufts Med Ctr Div Rheumatol Boston MA USA;
Bundesinst Arzneimittel &
Med Prod Bonn Germany;
Univ Paris 07 UFR Med Hop Lariboisiere AP HP Federat Rhumatol Paris France;
Geneva Univ Hosp Div Bone Dis Geneva Switzerland;
Univ Liege Dept Publ Hlth Epidemiol &
Hlth Econ CHU Sart Tilman B23 B-4000 Liege Belgium;
机译:我们可以识别患有骨关节炎进展的高风险的患者,谁会回应治疗? 重点关注骨关节炎的流行病学和表型(Vol 32,PG 179,2015)
机译:我们能否确定对治疗有反应的骨关节炎高危患者?侧重于骨关节炎的流行病学和表型
机译:我们能否确定对治疗有反应的骨关节炎高危患者?以生物标志物和脆弱为重点
机译:身体活动是骨关节炎进展的危险因素:机器学习的角度
机译:对膝骨关节炎患者的治疗偏爱的长期评估
机译:我们能否确定对治疗有反应的高骨关节炎进展风险患者?专注于骨关节炎的流行病学和表型
机译:我们能否确定对治疗有反应的高骨关节炎进展风险患者?专注于骨关节炎的流行病学和表型